These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88. Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases. Papp-Wallace KM; Bajaksouzian S; Abdelhamed AM; Foster AN; Winkler ML; Gatta JA; Nichols WW; Testa R; Bonomo RA; Jacobs MR Diagn Microbiol Infect Dis; 2015 May; 82(1):65-9. PubMed ID: 25737290 [TBL] [Abstract][Full Text] [Related]
89. Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinations. Kurz SG; Wolff KA; Hazra S; Bethel CR; Hujer AM; Smith KM; Xu Y; Tremblay LW; Blanchard JS; Nguyen L; Bonomo RA Antimicrob Agents Chemother; 2013 Dec; 57(12):6085-96. PubMed ID: 24060876 [TBL] [Abstract][Full Text] [Related]
90. Network models of TEM β-lactamase mutations coevolving under antibiotic selection show modular structure and anticipate evolutionary trajectories. Guthrie VB; Allen J; Camps M; Karchin R PLoS Comput Biol; 2011 Sep; 7(9):e1002184. PubMed ID: 21966264 [TBL] [Abstract][Full Text] [Related]
91. Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance. Baquero F; Coque TM; de la Cruz F Antimicrob Agents Chemother; 2011 Aug; 55(8):3649-60. PubMed ID: 21576439 [TBL] [Abstract][Full Text] [Related]
92. Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase. Papp-Wallace KM; Taracila M; Hornick JM; Hujer AM; Hujer KM; Distler AM; Endimiani A; Bonomo RA Antimicrob Agents Chemother; 2010 Jul; 54(7):2867-77. PubMed ID: 20421396 [TBL] [Abstract][Full Text] [Related]
94. Genetic constraints on protein evolution. Camps M; Herman A; Loh E; Loeb LA Crit Rev Biochem Mol Biol; 2007; 42(5):313-26. PubMed ID: 17917869 [TBL] [Abstract][Full Text] [Related]
95. Detection of five novel CTX-M-type extended spectrum beta-lactamases with one to three CTX-M-14 point mutations in isolates from Hefei, Anhui province, China. Li H; Li JB J Clin Microbiol; 2005 Aug; 43(8):4301-2. PubMed ID: 16082008 [No Abstract] [Full Text] [Related]
96. Evolution of TEM-type extended-spectrum beta-lactamases in clinical Enterobacteriaceae strains in Poland. Baraniak A; Fiett J; Mrówka A; Walory J; Hryniewicz W; Gniadkowski M Antimicrob Agents Chemother; 2005 May; 49(5):1872-80. PubMed ID: 15855509 [TBL] [Abstract][Full Text] [Related]
97. Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor. Galán JC; Morosini MI; Baquero MR; Reig M; Baquero F Antimicrob Agents Chemother; 2003 Aug; 47(8):2551-7. PubMed ID: 12878518 [TBL] [Abstract][Full Text] [Related]